Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491]

• Pratibha Pandey,
• Fahad Khan,
• Tarun Kumar Upadhyay,
• Moon Seungjoon,
• Moon Nyeo Park,
• Bonglee Kim

Affiliations

Pratibha Pandey

Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India

Fahad Khan

Department of Biotechnology, Noida Institute of Engineering and Technology, Greater Noida, UP, India; Corresponding author.

Tarun Kumar Upadhyay

Department of Biotechnology, Parul Institute of Applied Sciences and Centre of Research for Development, Parul University, Vadodara 391760, India

Moon Seungjoon

Chansol Hospital of Korean Medicine, 290, Buheung-ro, Bupyeong-gu, Incheon 21390, the Republic of Korea; Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea

Moon Nyeo Park

Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea

Bonglee Kim

Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea; Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, the Republic of Korea; Corresponding author at: Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun-gu, Seoul 02447, the Republic of Korea.